Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy.
Pharmaceuticals (Basel)
; 16(2)2023 Feb 16.
Article
en En
| MEDLINE
| ID: mdl-37259452
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Pharmaceuticals (Basel)
Año:
2023
Tipo del documento:
Article
País de afiliación:
Italia